{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T11:51:34Z","timestamp":1787226694050,"version":"build-2736575974"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2014,9,19]],"date-time":"2014-09-19T00:00:00Z","timestamp":1411084800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Trials"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1186\/1745-6215-15-367","type":"journal-article","created":{"date-parts":[[2014,9,19]],"date-time":"2014-09-19T23:00:55Z","timestamp":1411167655000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["A multicentre non-blinded randomised controlled trial to assess the impact of regular early specialist symptom control treatment on quality of life in malignant mesothelioma (RESPECT-MESO): study protocol for a randomised controlled trial"],"prefix":"10.1186","volume":"15","author":[{"given":"Samal","family":"Gunatilake","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fraser JH","family":"Brims","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carole","family":"Fogg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iain","family":"Lawrie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nick","family":"Maskell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen","family":"Forbes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Najib","family":"Rahman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steve","family":"Morris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reuben","family":"Ogollah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"Gerry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mick","family":"Peake","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liz","family":"Darlison","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anoop J","family":"Chauhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,9,19]]},"reference":[{"issue":"7","key":"2238_CR1","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1038\/sj.bjc.6604879","volume":"100","author":"C Rake","year":"2009","unstructured":"Rake C, Gilham C, Hatch J, Darnton A, Hodgson J, Peto J: Occupational, domestic and environmental mesothelioma risks in the British population: a case-control study. Br J Cancer. 2009, 100 (7): 1175-83. 10.1038\/sj.bjc.6604879.","journal-title":"Br J Cancer"},{"issue":"1","key":"2238_CR2","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1136\/jrnms-95-4","volume":"95","author":"FJ Brims","year":"2009","unstructured":"Brims FJ: Asbestos - a legacy and a persistent problem. J R Nav Med Serv. 2009, 95 (1): 4-11.","journal-title":"J R Nav Med Serv"},{"issue":"3","key":"2238_CR3","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1038\/sj.bjc.6602307","volume":"92","author":"JT Hodgson","year":"2005","unstructured":"Hodgson JT, McElvenny DM, Darnton AJ, Price MJ, Peto J: The expected burden of mesothelioma mortality in Great Britain from 2002 to 2050. Br J Cancer. 2005, 92 (3): 587-93.","journal-title":"Br J Cancer"},{"issue":"8949","key":"2238_CR4","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/S0140-6736(95)90462-X","volume":"345","author":"J Peto","year":"1995","unstructured":"Peto J, Hodgson JT, Matthews FE, Jones JR: Continuing increase in mesothelioma mortality in Britain. Lancet. 1995, 345 (8949): 535-9. 10.1016\/S0140-6736(95)90462-X.","journal-title":"Lancet"},{"issue":"3\u20134","key":"2238_CR5","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1038\/sj.bjc.6690105","volume":"79","author":"J Peto","year":"1999","unstructured":"Peto J, Decarli A, La Vecchia C, Levi F, Negri E: The European mesothelioma epidemic. Br J Cancer. 1999, 79 (3\u20134): 666-72.","journal-title":"Br J Cancer"},{"key":"2238_CR6","doi-asserted-by":"crossref","unstructured":"BTS statement on malignant mesothelioma in the UK. Thorax. 2007, 62 (Suppl 2): ii1-ii19.","DOI":"10.1136\/thx.2007.087619"},{"issue":"2","key":"2238_CR7","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1007\/s13665-013-0045-1","volume":"2","author":"FJ Brims","year":"2013","unstructured":"Brims FJ, Maskell NA: Prognostic factors for malignant pleural mesothelioma. Current Respiratory Care Reports. 2013, 2 (2): 100-8. 10.1007\/s13665-013-0045-1.","journal-title":"Current Respiratory Care Reports"},{"issue":"3","key":"2238_CR8","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1002\/cncr.20315","volume":"101","author":"PJ Hollen","year":"2004","unstructured":"Hollen PJ, Gralla RJ, Liepa AM, Symanowski JT, Rusthoven JJ: Adapting the Lung Cancer Symptom Scale (LCSS) to mesothelioma: using the LCSS-Meso conceptual model for validation. Cancer. 2004, 101 (3): 587-95. 10.1002\/cncr.20315.","journal-title":"Cancer"},{"issue":"14","key":"2238_CR9","doi-asserted-by":"publisher","first-page":"2636","DOI":"10.1200\/JCO.2003.11.136","volume":"21","author":"NJ Vogelzang","year":"2003","unstructured":"Vogelzang NJ, Rusthoven JJ, Symanowski J, Denham C, Kaukel E, Ruffie P, Gatzemeier U, Boyer M, Emri S, Manegold C, Niyikiza C, Paoletti P: Phase III study of pemetrexed in combination with cisplatin versus cisplatin alone in patients with malignant pleural mesothelioma. J Clin Oncol Off J Am Soc Clin Oncol. 2003, 21 (14): 2636-44. 10.1200\/JCO.2003.11.136.","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"issue":"1","key":"2238_CR10","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/S0167-8140(00)00158-4","volume":"55","author":"H Langendijk","year":"2000","unstructured":"Langendijk H, Aaronson NK, de Jong JM, ten Velde GP, Muller MJ, Wouters M: The prognostic impact of quality of life assessed with the EORTC QLQ-C30 in inoperable non-small cell lung carcinoma treated with radiotherapy. Radiother Oncol. 2000, 55 (1): 19-25. 10.1016\/S0167-8140(00)00158-4.","journal-title":"Radiother Oncol"},{"issue":"2\u20133","key":"2238_CR11","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/S0169-5002(00)00179-3","volume":"31","author":"A Montazeri","year":"2001","unstructured":"Montazeri A, Milroy R, Hole D, McEwen J, Gillis CR: Quality of life in lung cancer patients: as an important prognostic factor. Lung Cancer. 2001, 31 (2\u20133): 233-40.","journal-title":"Lung Cancer"},{"issue":"8","key":"2238_CR12","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1056\/NEJMoa1000678","volume":"363","author":"JS Temel","year":"2010","unstructured":"Temel JS, Greer JA, Muzikansky A, Gallagher ER, Admane S, Jackson VA, Dahlin CM, Blinderman CD, Jacobsen J, Pirl WF, Billings JA, Lynch TJ: Early palliative care for patients with metastatic non-small-cell lung cancer. N Engl J Med. 2010, 363 (8): 733-42. 10.1056\/NEJMoa1000678.","journal-title":"N Engl J Med"},{"issue":"9930","key":"2238_CR13","doi-asserted-by":"publisher","first-page":"1721","DOI":"10.1016\/S0140-6736(13)62416-2","volume":"383","author":"C Zimmermann","year":"2014","unstructured":"Zimmermann C, Swami N, Krzyzanowska M, Hannon B, Leighl N, Oza A, Moore M, Rydall A, Rodin G, Tannock I, Donner A, Lo C: Early palliative care for patients with advanced cancer: a cluster-randomised controlled trial. Lancet. 2014, 383 (9930): 1721-30. 10.1016\/S0140-6736(13)62416-2.","journal-title":"Lancet"},{"issue":"7","key":"2238_CR14","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1191\/0269216303pm814oa","volume":"17","author":"V Lidstone","year":"2003","unstructured":"Lidstone V, Butters E, Seed PT, Sinnott C, Beynon T, Richards M: Symptoms and concerns amongst cancer outpatients: identifying the need for specialist palliative care. Palliat Med. 2003, 17 (7): 588-95. 10.1191\/0269216303pm814oa.","journal-title":"Palliat Med"},{"issue":"2","key":"2238_CR15","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1016\/j.jpainsymman.2010.04.020","volume":"41","author":"SM Watanabe","year":"2011","unstructured":"Watanabe SM, Nekolaichuk C, Beaumont C, Johnson L, Myers J, Strasser F: A multicenter study comparing two numerical versions of the Edmonton Symptom Assessment System in palliative care patients. J Pain Symptom Manag. 2011, 41 (2): 456-68. 10.1016\/j.jpainsymman.2010.04.020.","journal-title":"J Pain Symptom Manag"},{"key":"2238_CR16","volume-title":"The EORTC QLQ C-30 Scoring Manual","author":"PM Fayers","year":"2001","unstructured":"Fayers PM, Aaronson NK, Bjordal K, Groenvold M, Curran D, Bottomley A: The EORTC QLQ C-30 Scoring Manual. 2001, European Organisation for Research and Treatment of Cancer: Brussels, 3","edition":"3"},{"issue":"15","key":"2238_CR17","doi-asserted-by":"publisher","first-page":"3172","DOI":"10.1200\/JCO.2004.09.147","volume":"22","author":"AK Nowak","year":"2004","unstructured":"Nowak AK, Stockler MR, Byrne MJ: Assessing quality of life during chemotherapy for pleural mesothelioma: feasibility, validity, and results of using the European Organization for Research and Treatment of Cancer Core Quality of Life Questionnaire and Lung Cancer Module. J ClinOncol. 2004, 22 (15): 3172-80. 10.1200\/JCO.2004.09.147.","journal-title":"J ClinOncol"},{"issue":"11","key":"2238_CR18","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1007\/s001270050272","volume":"35","author":"DJ Pevalin","year":"2000","unstructured":"Pevalin DJ: Multiple applications of the GHQ-12 in a general population sample: an investigation of long-term retest effects. Soc Psychiatry Psychiatr Epidemiol. 2000, 35 (11): 508-12. 10.1007\/s001270050272.","journal-title":"Soc Psychiatry Psychiatr Epidemiol"},{"issue":"4","key":"2238_CR19","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1378\/chest.108.4.1122","volume":"108","author":"VW Rusch","year":"1995","unstructured":"Rusch VW: A proposed new international TNM staging system for malignant pleural mesothelioma. From the International Mesothelioma Interest Group. Chest. 1995, 108 (4): 1122-8.","journal-title":"Chest"},{"key":"2238_CR20","volume-title":"QLQ-C-30 Scoring Manual (3rd Edition)","author":"P Fayers","year":"2001","unstructured":"Fayers P, Aaronson N, Bjordal K, Groenvold M, Curran D, Bottomley A, The EORTC: QLQ-C-30 Scoring Manual (3rd Edition). 2001, Brussels: European Organisation for Research and Treatment of Cancer"},{"key":"2238_CR21","volume-title":"National Health Service Reference Costs 2008\/09","author":"DOH","year":"2010","unstructured":"DOH: National Health Service Reference Costs 2008\/09. 2010, London: Department of Health"},{"key":"2238_CR22","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1177\/135581969800300410","volume":"3","author":"A Briggs","year":"1998","unstructured":"Briggs A, Gray A: The distribution of healthcare costs and their statistical analysis for economic evaluation. J Health Serv Res Policy. 1998, 3: 233-45.","journal-title":"J Health Serv Res Policy"},{"issue":"20","key":"2238_CR23","doi-asserted-by":"publisher","first-page":"2191","DOI":"10.1001\/jama.2013.281053","volume":"310","author":"World Medical A","year":"2013","unstructured":"World Medical A: World medical association declaration of Helsinki: ethical principles for medical research involving human subjects. JAMA. 2013, 310 (20): 2191-4.","journal-title":"JAMA"},{"issue":"3","key":"2238_CR24","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1111\/j.1752-699X.2011.00254.x","volume":"6","author":"FJ Brims","year":"2012","unstructured":"Brims FJ, Arif M, Chauhan AJ: Outcomes and complications following medical thoracoscopy. Clin Respir J. 2012, 6 (3): 144-9. 10.1111\/j.1752-699X.2011.00254.x.","journal-title":"Clin Respir J"},{"issue":"Suppl IV","key":"2238_CR25","first-page":"A159","volume":"65","author":"A Jeyabalan","year":"2010","unstructured":"Jeyabalan A, Pillai A, Smith S, Darby M, Ibrahim N, Maskell N: The value of a Regional Mesothelioma Multidisciplinary Team meeting - an audit. Thorax. 2010, 65 (Suppl IV): A159-","journal-title":"Thorax"},{"issue":"Suppl IV","key":"2238_CR26","doi-asserted-by":"publisher","first-page":"A106","DOI":"10.1136\/thx.2010.150979.20","volume":"65","author":"R Bhatnagar","year":"2010","unstructured":"Bhatnagar R, Earl S, Lansdell K, Howell T: Mesothelioma in the 21st Century. A 1-year survey of malignant mesothelioma in the South West of the UK. Thorax. 2010, 65 (Suppl IV): A106-","journal-title":"Thorax"},{"issue":"5","key":"2238_CR27","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1136\/thx.2007.081430","volume":"63","author":"A Chapman","year":"2008","unstructured":"Chapman A, Mulrennan S, Ladd B, Muers MF: Population based epidemiology and prognosis of mesothelioma in Leeds, UK. Thorax. 2008, 63 (5): 435-9. 10.1136\/thx.2007.081430.","journal-title":"Thorax"}],"container-title":["Trials"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1745-6215-15-367.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1745-6215-15-367\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1745-6215-15-367","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1745-6215-15-367.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,17]],"date-time":"2022-04-17T12:53:39Z","timestamp":1650200019000},"score":1,"resource":{"primary":{"URL":"https:\/\/trialsjournal.biomedcentral.com\/articles\/10.1186\/1745-6215-15-367"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,9,19]]},"references-count":27,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["2238"],"URL":"https:\/\/doi.org\/10.1186\/1745-6215-15-367","relation":{},"ISSN":["1745-6215"],"issn-type":[{"value":"1745-6215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,9,19]]},"assertion":[{"value":"23 July 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 September 2014","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 September 2014","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"367"}}